Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AFNT-211 by Affini-T Therapeutics for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
AFNT-211 is under clinical development by Affini-T Therapeutics and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
AFNT-211 by Affini-T Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
AFNT-211 is under clinical development by Affini-T Therapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...
AFNT-211 by Affini-T Therapeutics for Solid Tumor: Likelihood of Approval
AFNT-211 is under clinical development by Affini-T Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
AFNT-211 by Affini-T Therapeutics for Colorectal Cancer: Likelihood of Approval
AFNT-211 is under clinical development by Affini-T Therapeutics and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase...